Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iguratimod in Sjögren's Syndrome
NCT03023592Phase 2Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Feb 2017
- Primary completion
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of iguratimod in Sjögren's syndrome, sponsored by Peking Union Medical College Hospital. Status: unknown.
02
Drugs
iguratimod
03
Conditions
Sjögren's syndrome
Beyond the preview
Go deeper on NCT03023592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03023592.